In vivo Cell Therapy

RNA-Driven Cellular Reprogramming In Vivo

Enabling targeted in vivo cell reprogramming for next-generation therapies.

In vivo cell therapy leverages non-viral, nucleic acid-based approaches to engineer cells directly within the body.

Crystal NAX supports this emerging modality through intelligent design CAR encoding RNA and/or accessory genes to boost therapeutic activity, ligand bio-conjugation service,development of next-generation targeted LNP, and robust functional characterization. Our platform supports the development of in-vivo RNA-based applications that enable controlled, transient, and tissue-specific cellular modulation

Key Capabilities

RNA Engineering for Cellular Modulation

RNA design for transient expression and controlled activity
Support for diverse functional payloads
Optimization for in vivo performance

NAX Nucleic Acid Technology >>

Targeted Delivery Technologies

LNP systems designed for cell- and tissue-specific delivery
Surface-functionalized nanoparticles for enhanced targeting
Rapid screening of delivery performance in vivo

NAX LNP Technology >>

Integrated Characterization

Analytical assessment of RNA and LNP properties
Functional evaluation of cellular responses
Data-driven refinement of in vivo cell therapy strategies

NAX Characterization Technology >>

Related Services

Custom Synthesis

LNP Formulation

Catalog Product

Early-Phase Manufacturing

Talk to a scientist today

Free consultation